Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo

Title
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
Authors
Keywords
melanoma, vemurafenib-resistant, reactive oxygen, mitochondria, xenographs
Journal
Oncotarget
Volume 7, Issue 11, Pages -
Publisher
Impact Journals, LLC
Online
2016-02-13
DOI
10.18632/oncotarget.7289

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation